Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...

Conflict, displacement, and climate-driven droughts continue to hinder health access and control of vaccine-preventable diseases in the region ...

The start of a new year is always an exciting time, but 2025 brings the expectation of a lot of change to come.

The discovery has shed light on a complex blood interaction that has likely always been present in humans but was unnoticed ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Forrester (Nasdaq: FORR) projects that global technology spend will grow by 5.6% in 2025 to reach $4.9 trillion — up from $4.7 trillion in 2024 — refl ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...